Johnson & Johnson (JNJ)
245.26
-1.49
(-0.60%)
USD |
NYSE |
Mar 04, 16:00
245.29
+0.03
(+0.01%)
After-Hours: 20:00
Johnson & Johnson Cash from Investing (Quarterly) : -4.485B for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Gilead Sciences, Inc. | -1.835B |
| Eli Lilly & Co. | -2.802B |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Moderna, Inc. | -48.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.309B |
| Cash from Financing (Quarterly) | -1.369B |
| Free Cash Flow | 19.70B |
| Free Cash Flow Per Share (Quarterly) | 2.401 |
| Free Cash Flow to Equity (Quarterly) | 2.319B |
| Free Cash Flow to Firm (Quarterly) | 6.362B |
| Free Cash Flow Yield | 3.31% |